The potential to generate virtually any differentiated cell type from embryonic stem cells
(ESCs) offers the possibility to establish new models of mammalian development and to …

The potential usefulness of human embryonic stem cells for therapy derives from their ability
to form any cell in the body. This potential has been used to justify intensive research …

Human pluripotent stem cell (hPSC)-derived endothelial cells and their progenitors may
provide the means for vascularization of tissue-engineered constructs and can serve as …

The isolation of human induced pluripotent stem cells (iPSCs),, offers a new strategy for
modelling human disease. Recent studies have reported the derivation and differentiation of …

Human induced pluripotent stem cells (iPSCs) provide a potentially replenishable source for
the production of transfusable platelets. Here, we describe a method to generate …

Previous efforts to differentiate human embryonic stem cells (hESCs) into endothelial cells
have not achieved sustained expansion and stability of vascular cells. To define …

Human induced pluripotent stem cells (hiPSC) have been shown to differentiate into a
variety of replacement cell types. Detailed evaluation and comparison with their human …

In order to promote the uniform and reproducible differentiation of human embryonic stem
cells (HESCs) in response to exogenously added growth factors, we have developed a …

The extracellular microenvironment plays a significant role in controlling cellular behavior.
Identification of appropriate biomaterials that support cellular attachment, proliferation and …

Transplantation of endothelial cells (ECs) is a promising therapeutic approach for ischemic
disorders. In addition, the generation of ECs has become increasingly important for …